Novel uses of combined selective dopamine D2 receptor antagonists and 5-HT1A receptor agonists

Details for Australian Patent Application No. 2002221744 (hide)

Inventors Bartoszyk, Gerd

Agent Davies Collison Cave

Event Publications

2 August 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002221745-4-(biphenylcarbonylamino)piperidine derivatives as MTP inhibitors

2002221743-Absorption agents with a high swelling capacity, with a reduced tendency to cake